Envoy Medical (Envoy Medical) FCF Yield % : -28.48 (As of May. 11, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Envoy Medical's Trailing 12-Month Free Cash Flow is $-17.81 Mil, and Market Cap is $62.52 Mil. Therefore, Envoy Medical's FCF Yield % for today is -28.48%.

The historical rank and industry rank for Envoy Medical's FCF Yield % or its related term are showing as below:

COCH' s FCF Yield % Range Over the Past 10 Years
Min: -52.65 Med: 0 Max: 0
Current: -28.48

COCH's FCF Yield % is ranked worse than
79.7% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.63 vs COCH: -28.48

Envoy Medical's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Envoy Medical FCF Yield % Historical Data

The historical data trend for Envoy Medical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical FCF Yield % Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

-50.18

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Envoy Medical's FCF Yield %

For the Medical Devices subindustry, Envoy Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Envoy Medical's FCF Yield % falls into.

Envoy Medical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Envoy Medical's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-17.807	/	35.48776
	=	-50.18%

Envoy Medical's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	35.48776
	=	0.00%

Envoy Medical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Envoy Medical FCF Yield % Related Terms

Thank you for viewing the detailed overview of Envoy Medical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.